Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2007

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

sagopilone

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (1)

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00424060 - Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma | Biotech Hunter | Biotech Hunter